ATP-sensitive potassium channel activation induces angiogenesis in vitro and in vivo

Bukar Umaru, Anastasia Pyriochou, Vasileios Kotsikoris, Andreas Papapetropoulos, Stavros Topouzis

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Intense research is conducted to identify new molecular mechanisms of angiogenesis. Previous studies have shown that the angiogenic effects of hydrogen sulfide (H2S) depend on the activation of ATP-sensitive potassium channels (KATP) and that C-type natriuretic peptide (CNP), which can act through KATP, promotes endothelial cell growth. We therefore investigated whether direct KATP activation induces angiogenic responses and whether it is required for the endothelial responses to CNP or vascular endothelial growth factor (VEGF). Chick chorioallantoic membrane (CAM) angiogenesis was similarly enhanced by the direct KATP channel activator 2-nicotinamidoethyl acetate (SG-209) and by CNP or VEGF. The KATP inhibitors glibenclamide and 5-hydroxydecanoate (5-HD) reduced basal and abolished CNP-induced CAM angiogenesis. In vitro, the direct KATP openers nicorandil and SG-209 and the polypeptides VEGF and CNP increased proliferation and migration in bEnd.3 mouse endothelial cells. In addition, VEGF and CNP induced cord-like formation on Matrigel by human umbilical vein endothelial cells (HUVECs). All these in vitro endothelial responses were effectively abrogated by glibenclamide or 5-HD. In HUVECs, a small-interfering RNA-mediated decrease in the expression of the inwardly rectifying potassium channel (Kir) 6.1 subunit impaired cell migration and network morphogenesis in response to either SG-209 or CNP. We conclude that 1) direct pharmacologic activation of KATP induces angiogenic effects in vitro and in vivo, 2) angiogenic responses to CNP and VEGF depend on KATP activation and require the expression of the Kir6.1 KATP subunit, and 3) KATP activation may underpin angiogenesis to a variety of vasoactive stimuli, including H2S, VEGF, and CNP.

Original languageEnglish (US)
Pages (from-to)79-87
Number of pages9
JournalJournal of Pharmacology and Experimental Therapeutics
Volume354
Issue number1
DOIs
StatePublished - Jul 1 2015
Externally publishedYes

Fingerprint

C-Type Natriuretic Peptide
KATP Channels
Vascular Endothelial Growth Factor C
Vascular Endothelial Growth Factor A
Chorioallantoic Membrane
Glyburide
Human Umbilical Vein Endothelial Cells
Endothelial Cells
Nicorandil
Inwardly Rectifying Potassium Channel
In Vitro Techniques
Hydrogen Sulfide
Morphogenesis
Small Interfering RNA
Cell Movement
Acetates

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology

Cite this

ATP-sensitive potassium channel activation induces angiogenesis in vitro and in vivo. / Umaru, Bukar; Pyriochou, Anastasia; Kotsikoris, Vasileios; Papapetropoulos, Andreas; Topouzis, Stavros.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 354, No. 1, 01.07.2015, p. 79-87.

Research output: Contribution to journalArticle

Umaru, Bukar ; Pyriochou, Anastasia ; Kotsikoris, Vasileios ; Papapetropoulos, Andreas ; Topouzis, Stavros. / ATP-sensitive potassium channel activation induces angiogenesis in vitro and in vivo. In: Journal of Pharmacology and Experimental Therapeutics. 2015 ; Vol. 354, No. 1. pp. 79-87.
@article{4482498347634087b47142c565148bad,
title = "ATP-sensitive potassium channel activation induces angiogenesis in vitro and in vivo",
abstract = "Intense research is conducted to identify new molecular mechanisms of angiogenesis. Previous studies have shown that the angiogenic effects of hydrogen sulfide (H2S) depend on the activation of ATP-sensitive potassium channels (KATP) and that C-type natriuretic peptide (CNP), which can act through KATP, promotes endothelial cell growth. We therefore investigated whether direct KATP activation induces angiogenic responses and whether it is required for the endothelial responses to CNP or vascular endothelial growth factor (VEGF). Chick chorioallantoic membrane (CAM) angiogenesis was similarly enhanced by the direct KATP channel activator 2-nicotinamidoethyl acetate (SG-209) and by CNP or VEGF. The KATP inhibitors glibenclamide and 5-hydroxydecanoate (5-HD) reduced basal and abolished CNP-induced CAM angiogenesis. In vitro, the direct KATP openers nicorandil and SG-209 and the polypeptides VEGF and CNP increased proliferation and migration in bEnd.3 mouse endothelial cells. In addition, VEGF and CNP induced cord-like formation on Matrigel by human umbilical vein endothelial cells (HUVECs). All these in vitro endothelial responses were effectively abrogated by glibenclamide or 5-HD. In HUVECs, a small-interfering RNA-mediated decrease in the expression of the inwardly rectifying potassium channel (Kir) 6.1 subunit impaired cell migration and network morphogenesis in response to either SG-209 or CNP. We conclude that 1) direct pharmacologic activation of KATP induces angiogenic effects in vitro and in vivo, 2) angiogenic responses to CNP and VEGF depend on KATP activation and require the expression of the Kir6.1 KATP subunit, and 3) KATP activation may underpin angiogenesis to a variety of vasoactive stimuli, including H2S, VEGF, and CNP.",
author = "Bukar Umaru and Anastasia Pyriochou and Vasileios Kotsikoris and Andreas Papapetropoulos and Stavros Topouzis",
year = "2015",
month = "7",
day = "1",
doi = "10.1124/jpet.114.222000",
language = "English (US)",
volume = "354",
pages = "79--87",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "1",

}

TY - JOUR

T1 - ATP-sensitive potassium channel activation induces angiogenesis in vitro and in vivo

AU - Umaru, Bukar

AU - Pyriochou, Anastasia

AU - Kotsikoris, Vasileios

AU - Papapetropoulos, Andreas

AU - Topouzis, Stavros

PY - 2015/7/1

Y1 - 2015/7/1

N2 - Intense research is conducted to identify new molecular mechanisms of angiogenesis. Previous studies have shown that the angiogenic effects of hydrogen sulfide (H2S) depend on the activation of ATP-sensitive potassium channels (KATP) and that C-type natriuretic peptide (CNP), which can act through KATP, promotes endothelial cell growth. We therefore investigated whether direct KATP activation induces angiogenic responses and whether it is required for the endothelial responses to CNP or vascular endothelial growth factor (VEGF). Chick chorioallantoic membrane (CAM) angiogenesis was similarly enhanced by the direct KATP channel activator 2-nicotinamidoethyl acetate (SG-209) and by CNP or VEGF. The KATP inhibitors glibenclamide and 5-hydroxydecanoate (5-HD) reduced basal and abolished CNP-induced CAM angiogenesis. In vitro, the direct KATP openers nicorandil and SG-209 and the polypeptides VEGF and CNP increased proliferation and migration in bEnd.3 mouse endothelial cells. In addition, VEGF and CNP induced cord-like formation on Matrigel by human umbilical vein endothelial cells (HUVECs). All these in vitro endothelial responses were effectively abrogated by glibenclamide or 5-HD. In HUVECs, a small-interfering RNA-mediated decrease in the expression of the inwardly rectifying potassium channel (Kir) 6.1 subunit impaired cell migration and network morphogenesis in response to either SG-209 or CNP. We conclude that 1) direct pharmacologic activation of KATP induces angiogenic effects in vitro and in vivo, 2) angiogenic responses to CNP and VEGF depend on KATP activation and require the expression of the Kir6.1 KATP subunit, and 3) KATP activation may underpin angiogenesis to a variety of vasoactive stimuli, including H2S, VEGF, and CNP.

AB - Intense research is conducted to identify new molecular mechanisms of angiogenesis. Previous studies have shown that the angiogenic effects of hydrogen sulfide (H2S) depend on the activation of ATP-sensitive potassium channels (KATP) and that C-type natriuretic peptide (CNP), which can act through KATP, promotes endothelial cell growth. We therefore investigated whether direct KATP activation induces angiogenic responses and whether it is required for the endothelial responses to CNP or vascular endothelial growth factor (VEGF). Chick chorioallantoic membrane (CAM) angiogenesis was similarly enhanced by the direct KATP channel activator 2-nicotinamidoethyl acetate (SG-209) and by CNP or VEGF. The KATP inhibitors glibenclamide and 5-hydroxydecanoate (5-HD) reduced basal and abolished CNP-induced CAM angiogenesis. In vitro, the direct KATP openers nicorandil and SG-209 and the polypeptides VEGF and CNP increased proliferation and migration in bEnd.3 mouse endothelial cells. In addition, VEGF and CNP induced cord-like formation on Matrigel by human umbilical vein endothelial cells (HUVECs). All these in vitro endothelial responses were effectively abrogated by glibenclamide or 5-HD. In HUVECs, a small-interfering RNA-mediated decrease in the expression of the inwardly rectifying potassium channel (Kir) 6.1 subunit impaired cell migration and network morphogenesis in response to either SG-209 or CNP. We conclude that 1) direct pharmacologic activation of KATP induces angiogenic effects in vitro and in vivo, 2) angiogenic responses to CNP and VEGF depend on KATP activation and require the expression of the Kir6.1 KATP subunit, and 3) KATP activation may underpin angiogenesis to a variety of vasoactive stimuli, including H2S, VEGF, and CNP.

UR - http://www.scopus.com/inward/record.url?scp=84939425838&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939425838&partnerID=8YFLogxK

U2 - 10.1124/jpet.114.222000

DO - 10.1124/jpet.114.222000

M3 - Article

C2 - 25977483

AN - SCOPUS:84939425838

VL - 354

SP - 79

EP - 87

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 1

ER -